Latest News
May 19, 2026
In Vivo – Vie Ventures Looks To Fill Autoimmune Disease Funding Gap
Feb 24, 2026
In Vivo – 20 Voices: What Does 2026 Hold For Biopharma?
Feb 19, 2026
Treg pioneer Bluestone joins Vie Ventures as it builds autoimmune portfolio
Feb 19, 2026
Vie Ventures Names Jeff Bluestone, PhD, as Managing Director
Jan 21, 2026
Interview with Vie Ventures Co-Founders Dr. Steven St. Peter and Dr. Luke Evnin and Senior Advisor Dr. Louis DeGennaro
Jan 5, 2026